PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine)
Status:
Completed
Trial end date:
2016-09-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of panitumumab plus
cisplatin/gemcitabine (CisGem) combination chemotherapy in KRAS wild-type biliary tract
cancer patients without systemic pre-treatment, compared to the historical data and to the
randomised control group without the antibody, which verifies the historically based
assumption.